192 related articles for article (PubMed ID: 29328386)
1. Proteomics-based investigation of multiple stages of OSCC development indicates that the inhibition of Trx-1 delays oral malignant transformation.
Chen X; Hu Q; Wu T; Wang C; Xia J; Yang L; Cheng B; Chen X
Int J Oncol; 2018 Mar; 52(3):733-742. PubMed ID: 29328386
[TBL] [Abstract][Full Text] [Related]
2. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
[TBL] [Abstract][Full Text] [Related]
3. Metabolic changes during malignant transformation in primary cells of oral lichen planus: Succinate accumulation and tumour suppression.
Yang Q; Sun H; Wang X; Yu X; Zhang J; Guo B; Hexige S
J Cell Mol Med; 2020 Jan; 24(2):1179-1188. PubMed ID: 31793175
[TBL] [Abstract][Full Text] [Related]
4. 4NQO carcinogenesis: a mouse model of oral cavity squamous cell carcinoma.
Hawkins BL; Heniford BW; Ackermann DM; Leonberger M; Martinez SA; Hendler FJ
Head Neck; 1994; 16(5):424-32. PubMed ID: 7960739
[TBL] [Abstract][Full Text] [Related]
5. The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer.
Foy JP; Tortereau A; Caulin C; Le Texier V; Lavergne E; Thomas E; Chabaud S; Perol D; Lachuer J; Lang W; Hong WK; Goudot P; Lippman SM; Bertolus C; Saintigny P
Oncotarget; 2016 Jun; 7(24):35932-35945. PubMed ID: 27027432
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical Evaluation of GLUT-3 and GLUT-4 in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Feitosa SG; Viana KF; Luna ECM; Costa FWG; Cavalcante RB; Chaves FN; Chaves HV; Pereira KMA
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1779-1783. PubMed ID: 30049187
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin downregulation and Twist overexpression since early stages of oral carcinogenesis.
de Freitas Silva BS; Yamamoto-Silva FP; Pontes HA; Pinto Júnior Ddos S
J Oral Pathol Med; 2014 Feb; 43(2):125-31. PubMed ID: 23772858
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of a fluorescence visualization system for the detection of oral precancerous and early cancerous lesions.
Ohnishi Y; Fujii T; Ugaki Y; Yasui H; Watanabe M; Dateoka S; Kakudo K
Oncol Rep; 2016 Jul; 36(1):514-20. PubMed ID: 27121913
[TBL] [Abstract][Full Text] [Related]
9. Risk prediction for malignant conversion of oral epithelial dysplasia by hypoxia related protein expression.
Zhang X; Han S; Han HY; Ryu MH; Kim KY; Choi EJ; Cha IH; Kim J
Pathology; 2013 Aug; 45(5):478-83. PubMed ID: 23811806
[TBL] [Abstract][Full Text] [Related]
10. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
Cao J; Jin JQ; Deng DJ; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
[TBL] [Abstract][Full Text] [Related]
11. The hamster model of sequential oral oncogenesis.
Vairaktaris E; Spyridonidou S; Papakosta V; Vylliotis A; Lazaris A; Perrea D; Yapijakis C; Patsouris E
Oral Oncol; 2008 Apr; 44(4):315-24. PubMed ID: 18061531
[TBL] [Abstract][Full Text] [Related]
12. Mutations in long-lived epithelial stem cells and their clonal progeny in pre-malignant lesions and in oral squamous cell carcinoma.
Melis M; Zhang T; Scognamiglio T; Gudas LJ
Carcinogenesis; 2020 Nov; 41(11):1553-1564. PubMed ID: 32115621
[TBL] [Abstract][Full Text] [Related]
13. Targeting of CD40 and PD-L1 Pathways Inhibits Progression of Oral Premalignant Lesions in a Carcinogen-induced Model of Oral Squamous Cell Carcinoma.
Monteiro de Oliveira Novaes JA; Hirz T; Guijarro I; Nilsson M; Pisegna MA; Poteete A; Barsoumian HB; Fradette JJ; Chen LN; Gibbons DL; Tian X; Wang J; Myers JN; McArthur MJ; Bell D; William WN; Heymach JV
Cancer Prev Res (Phila); 2021 Mar; 14(3):313-324. PubMed ID: 33277316
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of oral cancer in diabetic animals is not associated with c-jun activation pathway.
Vairaktaris E; Goutzanis L; Kalokerinos G; Vassiliou S; Spyridonidou S; Avgoustidis D; Strantzias P; Lazaris A; Papageorgiou G; Ragos V; Yapijakis C; Patsouris E
J Craniomaxillofac Surg; 2007 Dec; 35(8):382-7. PubMed ID: 18023197
[TBL] [Abstract][Full Text] [Related]
15. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of benign lymphoadenosis of oral mucosa.
Li SX; Yu SF; Sun KH
World J Gastroenterol; 2005 Aug; 11(29):4536-40. PubMed ID: 16052684
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a new OSCC cell line derived from OLK and identification of malignant transformation-related proteins by differential proteomics approach.
Dong Y; Zhao Q; Ma X; Ma G; Liu C; Chen Z; Yu L; Liu X; Zhang Y; Shao S; Xiao J; Li J; Zhang W; Fu M; Dong L; Yang X; Guo X; Xue L; Fang F; Zhan Q; Zhang L
Sci Rep; 2015 Aug; 5():12668. PubMed ID: 26234610
[TBL] [Abstract][Full Text] [Related]
18. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
19. Oral-specific ablation of Klf4 disrupts epithelial terminal differentiation and increases premalignant lesions and carcinomas upon chemical carcinogenesis.
Paparella ML; Abrigo M; Bal de Kier Joffe E; Raimondi AR
J Oral Pathol Med; 2015 Nov; 44(10):801-9. PubMed ID: 25605610
[TBL] [Abstract][Full Text] [Related]
20. Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer.
Saintigny P; William WN; Foy JP; Papadimitrakopoulou V; Lang W; Zhang L; Fan YH; Feng L; Kim ES; El-Naggar AK; Lee JJ; Mao L; Hong WK; Lingen MW; Lippman SM
J Natl Cancer Inst; 2018 Mar; 110(3):250-7. PubMed ID: 29617836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
